Circulating and tissue markers in the longitudinal management of breast cancer patients.
Schwartz
M K
MK
Department of Clinical Chemistry, Memorial Sloan Kettering Cancer Center, New York, NY 10021.
D000951:Antigens, Neoplasm / Q000032:analysis; D014408:Biomarkers, Tumor / Q000032:analysis* / Q000097:blood; D001943:Breast Neoplasms / Q000097:blood / Q000737:chemistry* / Q000453:epidemiology / Q000628:therapy; D002272:Carcinoembryonic Antigen / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D009077:Mucins / Q000032:analysis; D009362:Neoplasm Metastasis; D009363:Neoplasm Proteins / Q000032:analysis* / Q000097:blood; D009364:Neoplasm Recurrence, Local; D011237:Predictive Value of Tests; D011379:Prognosis; D011446:Prospective Studies
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D009077:Mucins; D009363:Neoplasm Proteins